Patents Assigned to Vitruviae LLC
  • Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases
    Patent number: 11197910
    Abstract: The present invention relates to the use of phosphotidylserine or pathogenic sugar targeted therapeutics for the management and treatment of microbial infections, including Zika, Dengue, West Nile, Ebola, H1N1, enteroviruses, Leishmaniasis, Malaria and Coronaviruses SARS-COV.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: December 14, 2021
    Assignee: VITRUVIAE LLC
    Inventors: Mahiuddin Ahmed, Sonia Sequeira
  • CD3/CD25 antibodies for neuro-immune diseases
    Patent number: 11124568
    Abstract: The present invention relates to the use of anti-CD3 and anti-CD25 antibodies for the management and treatment of inflammatory diseases and psycho-immune disorders, such as depression, autism (ASD) and attention deficit/hyperactivity disorder (ADHD).
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: September 21, 2021
    Assignee: Vitruviae LLC
    Inventors: Mahiuddin Ahmed, Sonia Sequeira